What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report the issuance and sale of $500,000,000 in aggregate principal amount of HCA's 7 7/8% Notes due 2011. It serves as official notification to the SEC and investors of this significant financing transaction.

What are the key terms of the new debt issuance?

The key terms are that HCA issued $500,000,000 in aggregate principal amount of notes with a coupon rate of 7 7/8% and a maturity date in 2011. The notes are further broken down into a $100,000,000 note and a $400,000,000 note.

Does this filing specify how HCA intends to use the $500 million raised?

No, this specific 8-K filing does not detail the intended use of the $500 million raised from the note issuance. Typically, such details would be discussed in accompanying financial statements, management discussions, or subsequent SEC filings.

What are the implications for investors regarding this debt issuance?

For investors, this issuance means HCA is taking on additional long-term debt, increasing its financial leverage. The 7 7/8% interest rate provides a fixed cost of borrowing. Investors should assess how this new debt impacts the company's debt-to-equity ratio and overall financial risk, and monitor future disclosures for the deployment of these funds.

HCA 8-K SEC Disclosure — Jan 31, 2001

Summary

This 8-K filing from HCA - The Healthcare Company, dated January 31, 2001, announces a significant financing event: the issuance and sale of $500,000,000 in aggregate principal amount of its 7 7/8% Notes due 2011. This action indicates the company's intention to raise substantial capital, likely for operational expansion, debt refinancing, or strategic initiatives. Investors should pay close attention to the terms of these notes and the company's subsequent use of the proceeds to assess the impact on HCA's financial leverage and future growth prospects. The filing includes the relevant underwriting agreements and the notes themselves as exhibits. While the 8-K itself does not provide details on the use of proceeds, the issuance of long-term debt signals a strategic financial decision by HCA's management. Investors should monitor future filings for information regarding how this capital will be deployed and its effect on the company's financial health and shareholder value.

Key Highlights

1HCA - The Healthcare Company announced the issuance and sale of $500,000,000 principal amount of 7 7/8% Notes due 2011.
2The notes were issued under the Securities Act of 1933, as amended.
3The filing includes the Underwriting Agreement (Terms) dated January 23, 2001.
4Specific notes filed include a $100,000,000 note and a $400,000,000 note, both due 2011.
5This indicates a significant capital raise by the company.
6The event date reported is January 23, 2001.

HCA Healthcare, Inc. 8-K Report (Jan 31, 2001)

Summary

Key Highlights

Frequently Asked Questions